UGT1A1 polymorphism predicts irinotecan toxicity: Evolving proof
Journal Title: The AAPS Journal - Year 2001, Vol 3, Issue 3
Abstract
Authors and Affiliations
Sridhar Mani
Keywords
Related Articles
- EP ID EP682054
- DOI 10.1208/ps0303_commentary2
- Views 80
- Downloads 0
Shear-induced variability in the United States pharmacopeia apparatus 2: Modifications to the existing system
The hydrodynamics within the United States Pharmacopeia Apparatus 2 have been shown to be highly non-uniform with a potential to yield substantial variability in dissolution rate measurements. Through the use of readily...
Bioerodible injectable poly(ortho ester) for tetracycline controlled delivery to periodontal pockets: Preliminary trial in humans
The semisolid consistency of poly(ortho esters) (POEs) containing tetracycline free base allows direct injection in the periodontal pocket and shows sustained and almost constant in vitro release in phosphate buffer, pH...
Inhalation Devices and Patient Interface: Human Factors
The development of any inhalation product that does not consider the patient needs will fail. The needs of the patients must be identified and aligned with engineering options and physical laws to achieve a robust and in...
Application of the Biopharmaceutical Classification System in Clinical Drug Development—An Industrial View
The biopharmaceutical classification system (BCS) classifies compounds based on their solubility and permeability. Regulatory agencies and health organizations have utilized this classification system to allow dissolutio...
Comparison of Deconvolution-Based and Absorption Modeling IVIVC for Extended Release Formulations of a BCS III Drug Development Candidate
In vitro–in vivo correlations (IVIVC) are predictive mathematical models describing the relationship between dissolution and plasma concentration for a given drug compound. The traditional deconvolution/convoluti...